ESR1 and Gynecomastia: 4-Hydroxytamoxifen is used in multi-dose regimens in a number of indications including hyperplasia of the breast, infertility, early and advanced estrogen receptor-positive breast cancer, gynecomastia, and peripheral precocious puberty.